431 related articles for article (PubMed ID: 2523311)
1. T cell malignancy in Richter's syndrome presenting as hyper IgM. Induction and characterization of a novel CD3+, CD4-, CD8+ T cell subset from phytohemagglutinin-stimulated patient's CD3+, CD4+, CD8+ leukemic T cells.
Raziuddin S; Assaf HM; Teklu B
Eur J Immunol; 1989 Mar; 19(3):469-74. PubMed ID: 2523311
[TBL] [Abstract][Full Text] [Related]
2. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
3. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
Yang SY; Rhee S; Welte K; Dupont B
J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328
[TBL] [Abstract][Full Text] [Related]
4. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.
Hofmann B; Jakobsen KD; Odum N; Dickmeiss E; Platz P; Ryder LP; Pedersen C; Mathiesen L; Bygbjerg IB; Faber V
J Immunol; 1989 Mar; 142(6):1874-80. PubMed ID: 2564029
[TBL] [Abstract][Full Text] [Related]
5. Factor requirements for activation and proliferation steps of human CD2+CD3-CD4-CD8- early thymocytes.
Dalloul AH; Mossalayi MD; Dellagi K; Bertho JM; Debré P
Eur J Immunol; 1989 Nov; 19(11):1985-90. PubMed ID: 2574677
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
Sztein MB; Cuna WR; Kierszenbaum F
J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
[TBL] [Abstract][Full Text] [Related]
7. Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance.
Fujihashi K; Taguchi T; McGhee JR; Eldridge JH; Bruce MG; Green DR; Singh B; Kiyono H
J Immunol; 1990 Oct; 145(7):2010-9. PubMed ID: 1975820
[TBL] [Abstract][Full Text] [Related]
8. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
Ernst DN; Weigle WO; McQuitty DN; Rothermel AL; Hobbs MV
J Immunol; 1989 Mar; 142(5):1413-21. PubMed ID: 2521878
[TBL] [Abstract][Full Text] [Related]
10. Activation through CD3 molecule leads a number of human T cell clones to induce IgE synthesis in vitro by B cells from allergic and nonallergic individuals.
Romagnani S; Del Prete G; Maggi E; Ricci M
J Immunol; 1987 Mar; 138(6):1744-9. PubMed ID: 3102597
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones.
Patel SS; Wacholtz MC; Duby AD; Thiele DL; Lipsky PE
J Immunol; 1989 Aug; 143(4):1108-17. PubMed ID: 2526180
[TBL] [Abstract][Full Text] [Related]
12. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
13. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
Yoshizawa H; Chang AE; Shu SY
Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
[TBL] [Abstract][Full Text] [Related]
14. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
Matsushima GK; Stohlman SA
J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
[TBL] [Abstract][Full Text] [Related]
15. Mlsa generated suppressor cells. I. Suppression is mediated by double-negative (CD3+CD5+CD4-CD8-) alpha/beta T cell receptor-bearing cells.
Bruley-Rosset M; Miconnet I; Canon C; Halle-Pannenko O
J Immunol; 1990 Dec; 145(12):4046-52. PubMed ID: 1701781
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel human thymocyte subset with a phenotype of CD3- CD4+ CD8 alpha + beta-1. Possible progeny of the CD3- CD4- CD8- subset.
Hori T; Cupp J; Wrighton N; Lee F; Spits H
J Immunol; 1991 Jun; 146(12):4078-84. PubMed ID: 1828260
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
18. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors.
Herzog WR; Ferreri NR; Ptak W; Askenase PW
J Immunol; 1989 Nov; 143(10):3125-33. PubMed ID: 2478617
[TBL] [Abstract][Full Text] [Related]
19. Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA.
Wood GS; Dubiel C; Mueller C; Abel EA; Hoppe RT; Edinger A; Weissman I; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1545-52. PubMed ID: 1828937
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of mature B (IgM+, B220+) and T (CD3+) lymphocytes in scid mice.
Carroll AM; Hardy RR; Bosma MJ
J Immunol; 1989 Aug; 143(4):1087-93. PubMed ID: 2473116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]